Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 11040
Country/Region: Ethiopia
Year: 2017
Main Partner: United Nations High Commissioner for Refugees
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: enumerations.State/PRM
Total Funding: $811,333 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $49,794
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $14,676
Care: Pediatric Care and Support (PDCS) $51,890
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $80,533
Biomedical Prevention: Injection Safety (HMIN) $0
Testing: HIV Testing and Counseling (HVCT) $1,666
Sexual Prevention: Other Sexual Prevention (HVOP) $231,028
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $74,219
Treatment: Adult Treatment (HTXS) $292,495
Treatment: Pediatric Treatment (PDTX) $15,032
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST By Key Population: FSW, Negative 2018 340
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 28,332
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 21,594
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 494
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 468
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 545
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 561
HTS_TST Sum of Test Result disaggregates 2018 482
HTS_TST_POS By Key Population: FSW, Positive 2018 19
HTS_TST_POS By Test Result: Positive 2018 482
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 863
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 41
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 44
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 33
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 340
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 340
PMTCT_ART Already on ART at beginning of current pregnancy 2018 124
PMTCT_ART New on ART 2018 383
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 507
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,188
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 408
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 261
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 69
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 46
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 32
PMTCT_STAT By Age (Numerator): 20-24 2018 11,594
PMTCT_STAT By Age (Numerator): 25-49 2018 11,594
PMTCT_STAT By Number of known positives: 20-24 2018 91
PMTCT_STAT By Number of known positives: 25-49 2018 91
PMTCT_STAT By Number of new positives: 20-24 2018 196
PMTCT_STAT By Number of new positives: 25-49 2018 196
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,188
PMTCT_STAT_den By Age (Denominator): 20-24 2018 11,594
PMTCT_STAT_den By Age (Denominator): 25-49 2018 11,594
PP_PREV Age/sex: 10-14 Female 2018 515
PP_PREV Age/sex: 10-14 Male 2018 515
PP_PREV Age/sex: 15-19 Female 2018 1,240
PP_PREV Age/sex: 15-19 Male 2018 1,195
PP_PREV Age/sex: 20-24 Female 2018 1,490
PP_PREV Age/sex: 20-24 Male 2018 1,305
PP_PREV Age/sex: 25-49 Female 2018 3,090
PP_PREV Age/sex: 25-49 Male 2018 3,050
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 12,400
PP_PREV Sum of Age/Sex disaggregates 2018 12,400
TX_CURR Aggregated Age/Sex: <15 Female 2018 112
TX_CURR Aggregated Age/Sex: <15 Male 2018 111
TX_CURR Aggregated Age/Sex: 15+ Female 2018 984
TX_CURR Aggregated Age/Sex: 15+ Male 2018 983
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 2,190
TX_CURR Sum of Aggregated Age/Sex <15 2018 223
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 1,967
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 2,190
TX_NEW FSW 2018 12
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 426
TX_NEW Pregnancy status 2018 275
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 204
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 112
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 111
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 984
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 983
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 2,190
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 2,190
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 112
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 111
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 984
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 983
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 204
VMMC_CIRC By Age: 15-19 2018 750
VMMC_CIRC By Age: 20-24 2018 600
VMMC_CIRC By Age: 25-29 2018 600
VMMC_CIRC By Age: 30-49 2018 507
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 2,457
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 2,457
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 2,457
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 1,350